{
    "organizations": [],
    "uuid": "c0032a28b5ac9b9c0280301e440ac7a409820b4d",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/05/31/globe-newswire-axovant-to-present-at-two-upcoming-investor-conferences.html",
    "ord_in_thread": 0,
    "title": "Axovant to Present at Two Upcoming Investor Conferences",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "BASEL, Switzerland, May 31, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ:AXON) today announced that Pavan Cheruvu, M.D., chief executive officer, will present a corporate overview at the Jefferies 2018 Global Healthcare Conference on June 7, 2018 at 9:00 a.m. ET, and at the JMP Securities Life Science Conference on June 21, 2018 at 9:00 a.m. ET.\nA live webcast will be available for each conference in the Investors section of Axovant's website at www.axovant.com . A replay will be available for 30 days following each conference.\nAbout Axovant Sciences\nAxovant is a clinical-stage biopharmaceutical company dedicated to advancing innovative treatments for patients with serious neurologic and neuropsychiatric conditions. Axovant is committed to developing and commercializing a pipeline of product candidates by identifying and developing novel treatments for unmet needs in neurology and psychiatry.\nFor more information, visit www.axovant.com .\nContacts:\nInvestors\nTricia Truehart\n(631) 892-7014\ninvestors@axovant.com\nMedia\nPaul Davis\n(646) 495-5310\nmedia@axovant.com\nSOURCE Axovant Sciences\nSource:Axovant Sciences Ltd.",
    "published": "2018-05-31T15:00:00.000+03:00",
    "crawled": "2018-05-31T16:53:34.019+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "basel",
        "switzerland",
        "may",
        "globe",
        "newswire",
        "axovant",
        "science",
        "nasdaq",
        "axon",
        "today",
        "announced",
        "pavan",
        "cheruvu",
        "chief",
        "executive",
        "officer",
        "present",
        "corporate",
        "overview",
        "jefferies",
        "global",
        "healthcare",
        "conference",
        "june",
        "et",
        "jmp",
        "security",
        "life",
        "science",
        "conference",
        "june",
        "et",
        "live",
        "webcast",
        "available",
        "conference",
        "investor",
        "section",
        "axovant",
        "website",
        "replay",
        "available",
        "day",
        "following",
        "conference",
        "axovant",
        "science",
        "axovant",
        "biopharmaceutical",
        "company",
        "dedicated",
        "advancing",
        "innovative",
        "treatment",
        "patient",
        "serious",
        "neurologic",
        "neuropsychiatric",
        "condition",
        "axovant",
        "committed",
        "developing",
        "commercializing",
        "pipeline",
        "product",
        "candidate",
        "identifying",
        "developing",
        "novel",
        "treatment",
        "unmet",
        "need",
        "neurology",
        "psychiatry",
        "information",
        "visit",
        "contact",
        "investor",
        "tricia",
        "truehart",
        "investor",
        "medium",
        "paul",
        "davis",
        "medium",
        "source",
        "axovant",
        "science",
        "source",
        "axovant",
        "science",
        "ltd"
    ]
}